NLRP3 and colitis: In line with previous studies showing a role for NLRP3 inflammasome in DSS colitis etiopathogenesis [14,15], we found an increased expression of both IL1B mRNA and inflammasome components, as well as protein levels of pro-Caspase-1, in colonic tissue of DSS-treated mice.